cAMP: Mapping a second messenger
, known as cAMP, acts as what the Nobel prize–winning neuroscientist Paul Greengard called a “second messenger” in regulating cellular functions such as growth and specialization, protein expression, and gene transcription by relaying extracellular signals to the cell’s interior.
In disease, intracellular pathways control cytokine secretion, resistance to toxins and pathological events by balancing the activity of enzymes, which adjust intracellular cAMP levels. Researchers recently have recognized that receptors can regulate cAMP production not only from the cell surface but also from intracellular membranes.
cAMP can diffuse rapidly, but under normal conditions, its concentration varies from place to place within a cell. It can cause highly localized downstream effects, suggesting that cellular compartmentalization underlines selective cellular responses. To investigate the impact of cAMP production when initiated from endocytic vesicles, a team led by of Duke University and of the University of California, San Francisco, used localized optical stimulation of cAMP synthesis and quantitative mass spectrometry to determine how compartmentalized cAMP production impacts downstream responses assessed through protein phosphorylation. was published in the Journal of Biological Chemistry.

“We sought to determine the overall functional significance of generating cAMP from internal membranes relative to the plasma membrane,” von Zastrow said.
The researchers seek to delineate the fundamental principles by which cells and tissues mount physiologically appropriate responses to a range of external and internal chemical inputs. They also are investigating the cellular basis of receptor-mediated drug action to identify paths for improving therapeutic efficacy.
“The first main takeaway is that generating cAMP from endosomes has widespread downstream effects,” von Zastrow said. “We initially thought we’d see only a small number of differences, but we identified many changes in the cellular phosphoproteome that result from endosome-generated cAMP relative to cAMP generated from the plasma membrane.”
The authors shed light on a less understood cellular signaling aspect: Location-encoded signaling is not restricted to increased protein phosphorylation or to effects mediated by the activity of a cAMP-dependent protein kinase such as protein kinase A, or PKA, in the nucleus. cAMP binds with and activates PKA, which then phosphorylates the protein to elicit cellular reactions.
The study also identified proteins that are dephosphorylated selectively in response to endosome-localized cAMP production and in sequences that do not correspond to PKA consensus sites. “Broadly speaking, our results show that producing cAMP from endosomes has potential to fundamentally ‘re-wire’ downstream cellular signaling by phosphorylation,” von Zastrow said.
The researchers were fascinated to see how multiple proteins are phosphorylated preferentially in response to cAMP produced from endosomes and to see proteins that are dephosphorylated selectively on distinct sites relative to those phosphorylated by PKA. Their cell culture model had tightly controlled variables, so the team cautions against directly extending their results to physiological systems or therapeutics. However, there are potentially profound biomedical implications for future studies.
This collaborative project involved researchers with various backgrounds, and each had different expectations, von Zastrow said. “Dr. Tsvetanova and I would frequently place bets on what results would be obtained. The data was so rich and clear that each one of us was surprised — to the degree that we generally forgot what the original bets were in the first place.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.